Molina Healthcare director receives stock grant

Molina Healthcare director Barbara L. Brasier received a grant of 405 shares of common stock as compensation for board service.

Accepted by SEC EDGAR 04/02/2026 - 04:44 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Molina Healthcare director Barbara L. Brasier received a grant of 405 shares of common stock as compensation for board service. The award was made on April 1, 2026 under the company’s 2025 Equity Incentive Plan. The quarterly grant was valued at $55,000, based on the $135.82 closing price of Molina Healthcare stock that day. Brasier now directly holds 5,581 shares following this non‑market, compensation-related acquisition.

Insider Trade Summary

Grant/Award: 405 shares

Grant/Award 1 txn

Insider BRASIER BARBARA L

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	405	$135.82	$55K

Holdings After Transaction: Common Stock — 5,581 shares (Direct)

Holdings Before and After: Common Stock, 5,176 to 5,581 shares (Direct)

Footnotes (3)

1. F1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
2. F2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares.
3. F3. Represents the closing price of the Issuer's common stock on April 1, 2026.

Key Figures

Shares granted: 405 shares Grant pricing: $135.82 per share Quarterly equity award value: $55,000 +2 more

5 metrics

Shares granted 405 shares Director equity grant on April 1, 2026

Grant pricing $135.82 per share Closing price on April 1, 2026 used for grant

Quarterly equity award value $55,000 One quarter of annual director equity award

Annual equity award value $220,000 Aggregate annual equity award to each director

Shares held after grant 5,581 shares Director’s direct holdings following transaction

Key Terms

2025 Equity Incentive Plan, annual equity award, Common Stock

3 terms

2025 Equity Incentive Plan financial

"Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director."

annual equity award financial

"The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted..."

Common Stock financial

"Represents the closing price of the Issuer's common stock on April 1, 2026."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Molina Healthcare (MOH) director Barbara L. Brasier report in this Form 4?

Barbara L. Brasier reported receiving 405 shares of Molina Healthcare common stock as a grant. The shares were awarded as director compensation under the 2025 Equity Incentive Plan and were not bought on the open market, reflecting routine equity-based board pay.

At what price were Barbara L. Brasier’s Molina Healthcare (MOH) shares valued?

The 405 granted shares were valued at the April 1, 2026 closing price of $135.82 per share. This price was used to translate a $55,000 quarterly equity award into a specific share count for the director.

How large is Barbara L. Brasier’s quarterly equity award from Molina Healthcare (MOH)?

Her quarterly equity award was set at $55,000 in Molina Healthcare stock. This is one quarter of a $220,000 annual equity award for each director, with the number of shares determined by the stock’s closing price on the grant date.

How many Molina Healthcare (MOH) shares does Barbara L. Brasier hold after this grant?

After receiving the 405-share grant, Barbara L. Brasier directly holds 5,581 shares of Molina Healthcare common stock. This figure reflects her updated direct ownership position immediately following the reported equity award transaction.

Was Barbara L. Brasier’s Molina Healthcare (MOH) transaction an open-market purchase or sale?

The transaction was a grant of 405 shares as compensation, not an open-market trade. It represents a non-cash equity award under the 2025 Equity Incentive Plan, classified as an acquisition due to a grant or award rather than a discretionary buy or sell.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BRASIER BARBARA L

(Last) (First) (Middle)

200 OCEANGATE

SUITE 100

(Street)

LONG BEACH CALIFORNIA 90802

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A(1)		405(2)	A	$135.82(3)	5,581	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares.

3. Represents the closing price of the Issuer's common stock on April 1, 2026.

Remarks:

	Jeff D. Barlow, by power of attorney for Barbara L. Brasier	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)